The Effect of Moringa oleifera on High Fat Diet and Streptozotocin Induced Diabetic Rats The Antihyperglycemic Effect of Moringa oleifera
Iranian Journal of Pharmaceutical Sciences,
Vol. 17 No. 2 (2021),
1 April 2021
,
Page 11-24
https://doi.org/10.22037/ijps.v17.40283
Abstract
Moringa oleifera has been used in many regions of the world at the level of folk medicine as a remedy for numerous diseases including the treatment of type 2 diabetes. This study aims to investigate the antidiabetic activity of the methanolic extract of M. oleifera leaves in type 2 diabetes mellitus in animal model induced by fat rich diet and the use of the diabetogenic agent, streptozotocin (STZ) in male Wistar rats. A daily dose of 300 mg/kg of M. oleifera extract (MOE) was administered to diabetic male Wistar rats that had been induced by high fat diet feeding for one month followed by intraperitoneal injection of 40mg/kg of streptozotocin. After three weeks of MOE treatment, blood glucose concentration, lipid profile markers, urea, and creatinine were assayed. Food intake was measured daily and body weight was measured weekly. After three weeks of treatment, MOE significantly decreased the blood glucose of the tested rats, and a marked decrease of triglyceride also was noticed. Regarding renal function indicators, MOE significantly decreased the serum urea level of diabetic rats. However, no change has been noticed in the serum creatinine level in all experimental groups. The findings in the present study suggest that M. oleifera can significantly alleviate hyperglycemia, and hyperlipidemia in diabetic rats. M. oleifera could be a potential treatment of type 2 diabetic patients.
- Type 2 diabetes mellitus
- herbal extract
- hyperglycemia
- glucose
- diabetes complications
- Wistar rats
How to Cite
References
[2] Skyler JS, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes (2017) 66 (2): 241-55.
[3] Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J. Diabetes (2015) 6 (3): 456-80.
[4] Montane J, Cadavez L, Novials A. Stress and the inflammatory process: A major cause of pancreatic cell death in type 2 diabetes. Diabetes Metab. Syndr. Obes. (2014) 7: 25-34.
[5] Kaneto H. Pancreatic β-cell Glucose Toxicity in Type 2 Diabetes Mellitus. Curr. Diabetes Rev. (2015) 11 (1): 2-6.
[6] Khodabandehloo H, Gorgani-Firuzjaee S, Panahi G, Meshkani R. Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction. Transl. Res. (2016) 167 (1): 228-56.
[7] Inzucchi SE, et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Spectr. (2012) 25 (3): 154-71.
[8] Kalva S, Fatima N, Raghunandan N, Samreen S. Insulinomimetic effect of citrullus colocynthis roots in STZ challenged rat model. Iran. J. Pharm. Sci. (2018) 14 (3): 49-66.
[9] El-Amin M, et al. Anti-diabetic effect of Murraya koenigii (L) and Olea europaea (L) leaf extracts on streptozotocin induced diabetic rats. Pak. J. Pharm. Sci. (2013) 26 (2): 359-65.
[10] Teugwa CM, Mejiato PC, Zofou D, Tchinda BT, Boyom FF. Antioxidant and antidiabetic profiles of two African medicinal plants: Picralima nitida (Apocynaceae) and Sonchus oleraceus (Asteraceae). BMC Complement. Altern. Med. (2013) 13: 175.
[11] Adefegha SA, Oboh G. In vitro inhibition activity of polyphenol-rich extracts from Syzygium aromaticum (L.) Merr. & Perry (Clove) buds against carbohydrate hydrolyzing enzymes linked to type 2 diabetes and Fe2+-induced lipid peroxidation in rat pancreas. Asian Pac. J. Trop. Biomed. (2012) 2 (10): 774-81.
[12] Ríos JL, Francini F, Schinella GR. Natural Products for the Treatment of Type 2 Diabetes Mellitus. Planta Med. (2015) 81 (12–13): 975-94.
[13] Chinsembu KC. Diabetes mellitus and nature’s pharmacy of putative antidiabetic plants. J. Herb. Med. (2019) 15: 100-230.
[14] Brilhante RSN, et al. Research advances on the multiple uses of Moringa oleifera: A sustainable alternative for socially neglected population. Asian. Pac. J. Trop. Med. (2017) 10 (7): 621-30.
[15] Leone A, Spada A, Battezzati A, Schiraldi A, Aristil J, Bertoli S. Cultivation, genetic, ethnopharmacology, phytochemistry and pharmacology of Moringa oleifera leaves: An overview. Int. J. Mol. Sci. (2015) 16 (6): 12791-835.
[16] Irfan HM, Asmawi MZ, Khan NAK, Sadikun A, Mordi MN. Anti-diabetic activity-guided screening of aqueous-ethanol Moringa oleifera extracts and fractions: Identification of marker compounds. Trop. J. Pharm. Res. (2017) 16 (3): 543-52.
[17] Ndong M, Uehara M, Katsumata SI, Suzuki K. Effects of oral administration of Moringa oleifera Lam on glucose tolerance in Goto-Kakizaki and wistar rats. J. Clin. Biochem. Nutr. (2007) 40 (3):229-33.
[18] Kar A, Choudhary BK, Bandyopadhyay NG. Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J. Ethnopharmacol. (2003) 84 (1): 105-8.
[19] Anyanwu Anthony Chinedu, Salako Olanrewaju Alani. AOO. Effect of the Ethanolic Leaf Extract of Moringa oleifera on Insulin Resistance in Streptozotocin Induced Diabetic Rats. J. Plant. Sci. (2014) 2 (6-1): 5-12.
[20] Philip G. Reeves, Forrest H. Nielsen, George C. Fahey J. AIN-93 Purified Diets for Laboratory Rodents: Final Report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J. Nutr. (1993) 123: 139-51.
[21] Furman BL. Streptozotocin-Induced Diabetic Models in Mice and Rats. Curr. Protoc. Pharmacol. (2015) 70: 5.47.1-5.47.20.
[22] Jaiswal D, Kumar Rai P, Kumar A, Mehta S, Watal G. Effect of Moringa oleifera Lam. leaves aqueous extract therapy on hyperglycemic rats. J. Ethnopharmacol. (2009) 123 (3): 392-6.
[23] Yassa HD, Tohamy AF. Extract of Moringa oleifera leaves ameliorates streptozotocin-induced Diabetes mellitus in adult rats. Acta. Histochem. (2014) 116 (5): 844-54.
[24] Jiao Y, Wang X, Jiang X, Kong F, Wang S, Yan C. Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet- and streptozotocin-induced type 2 diabetes in rats. J. Ethnopharmacol. (2017) 199: 119-27.
[25] Zephy D, Ahmad J. Type 2 diabetes mellitus: Role of melatonin and oxidative stress. Diabetes Metab. Syndr. (2015) 9 (2): 127-31.
[26] Atawodi, et al. Evaluation of the polyphenol content and antioxidant properties of methanol extracts of the leaves, stem, and root barks of Moringa oleifera Lam. J. Med. Food (2010) 13 (3):710-16.
[27] Olayaki LA, Irekpita JE, Yakubu MT, Ojo OO. Methanolic extract of Moringa oleifera leaves improves glucose tolerance, glycogen synthesis and lipid metabolism in alloxan-induced diabetic rats. J. Basic. Clin. Physiol. Pharmacol. (2015) 26 (6):585-93.
[28] Jahani R, Mojab F, Mahboubi A, Nasiri A, Tahamtani A, Faizi M. An in-vivo study on anticonvulsant, anxiolytic, and sedative-hypnotic effects of the polyphenol-rich Thymus Kotschyanus extract; evidence for the involvement of GABAa receptors. Iran. J. Pharm. Res. (2019) 18 (3): 1456-65.
[29] Jahani R, Khaledyan D, Jahani A, Jamshidi E, Kamalinejad M, Khoramjouy M, Faizi M. Evaluation and comparison of the antidepressant-like activity of Artemisia dracunculus and Stachys lavandulifolia ethanolic extracts: an in vivo study. Res. Pharm. Sci.(2019) 14 (6): 544-53.
[30] Ozder A. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: A cross-sectional study. Lipids Health Dis. (2014) 13: 183.
[31] Stamouli M, Pouliakis A, Mourtzikou A, Skliris A, Panagiotou I, Mournianakis E, Totos G. Evaluation of the lipid profile in type 2 diabetes mellitus patients in Greece. Clin. Lab. (2014) 60 (10): 1593-600.
[32] Rosenblit PD. Common medications used by patients with type 2 diabetes mellitus: What are their effects on the lipid profile?. Cardiovasc. Diabetol. (2016) 15: 95.
[33] Divi S, Bellamkonda R, Dasireddy S. Evaluation of antidiabetic and antihyperlipedemic potential of aqueous extract of Moringa oleifera in fructose fed insulin resistant and STZ induced diabetic. Asian J. Pharm. Clin. Res. (2012) 5 (1): 67-72.
[34] Abd El Latif A, El Bialy BES, Mahboub HD, Abd Eldaim MA. Moringa oleifera leaf extract ameliorates alloxan-induced diabetes in rats by regeneration of β cells and reduction of pyruvate carboxylase expression. Biochem. Cell Biol. (2014) 92 (5): 413-19.
[35] Aldukhayel A. Prevalence of diabetic nephropathy among type 2 diabetic patients in some of the arab countries. Int. J. Heal. Sci. (2017) 11 (1): 60-63.
[36] Hadjadj S, et al. Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes. Diabetologia (2016) 59 (1): 208-16.
[37] Guo C, Dong Y, Zhu H, Liu Y, Xie G. Ameliorative effects of protodioscin on experimental diabetic nephropathy. Phytomedicine (2018) 51: 77-83.
- Abstract Viewed: 104 times
- IJPS_Volume 17_Issue 2_Pages 11-24 Downloaded: 25 times